IPP Bureau
Sun Pharma acquires rights for Oxra, Oxramet and Oxraduo from AstraZeneca
By IPP Bureau - May 28, 2021
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
By IPP Bureau - May 27, 2021
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
By IPP Bureau - May 27, 2021
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
Sun Pharma Q4 FY21 net profit up 124%
By IPP Bureau - May 27, 2021
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Pfizer registers Q4FY21net profit at Rs 100 Cr
By IPP Bureau - May 26, 2021
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
By IPP Bureau - May 26, 2021
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
By IPP Bureau - May 25, 2021
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
Glenmark receives ANDA approval for Icatibant Injection
By IPP Bureau - May 25, 2021
This marks Glenmark's first synthetic decapeptide injectable approval
Bal Pharma launches BALflu, Favipiravir formulation in India
By IPP Bureau - May 25, 2021
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Everest Organics launches 'Posaconazole' API
By IPP Bureau - May 25, 2021
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Astrazeneca Pharma India Q4FY21 net profit up at Rs 27.27 Cr
By IPP Bureau - May 25, 2021
The company has reported total income of Rs.826.40 crores for FY 2020-21
Alkem Q4FY21 consolidated PAT drops QoQ to Rs. 239.99 Cr
By IPP Bureau - May 25, 2021
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
Lincoln consolidated Q4FY21 net profit at Rs. 12.57 Cr
By IPP Bureau - May 25, 2021
The company plans to enter the EU markets in FY22
Nanoform and Celanese explore ways to enhance drug delivery
By IPP Bureau - May 25, 2021
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Panacea Biotec to manufacture 10 crore doses per year of Sputnik V
By IPP Bureau - May 24, 2021
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
